Colchicine is used in the treatment of gouty arthritis, familial Medit
erranean fever, amyloidosis, Behcet disease and dermatoses, Myoneuropa
thy is a rare side-effect reported either with intoxication or in elde
rly patients with chronic renal insufficiency causing elevated plasma
drug levels. We report the first two cases of myoneuropathy in childre
n, both taking appropriate doses of colchicine, and having normal rena
l function. The myoneuropathic changes were reversible after stopping
treatment. The cause of colchicine myoneuropathy is unclear. Conclusio
n In children treated with colchicine, neuromuscular phenomena of unkn
own aetiology may be related to tl-le drug, even with a lack of intoxi
cation or renal insufficiency.